IL6 and diabetic kidney disease: In a hyperglycemic environment, the elevation of IL-6 in MCs led to cell apoptosis (89) and promoted cell proliferation, inflammation and fibrotic changes through the IL-6/JAK2/STAT3 pathway, thereby hastening the progression of DKD (90).